Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD

Abstract

IntroductionThis study aimed to determine the effect of combining positive airway pressure (PAP) therapy and mandibular advancement device (MAD) in patients with severe obstructive sleep apnea (OSA) who were pressure intolerant for PAP and were unresponsive to MAD.MethodsThis retrospective study reviewed the medical records of severe OSA patients with apnea-hypopnea index (AHI) ≥ 30/hr who were diagnosed between October 1, 2008 and June 30, 2014. Patients were initially treated with 2 weeks of PAP, and those who were intolerant to high-pressure PAP (≥15 cm H2O) were switched to 12 weeks of MAD, which is a monobloc designed at 75% of maximum protrusion. Patients who had high residual AHI (≥15/hr) on MAD underwent 12 weeks of combination therapy (CT) with MAD and CPAP and were enrolled in the present study. Enrolled subjects who completed the 12-week CT were followed-up until June 30, 2016.ResultsA total of 14 male patients were included. All three treatments effectively reduced AHI, oxygen desaturation index (ODI), and total sleep time with SpO2 <90% (% TST-SpO2<90%) compared to pretreatment values. The residual AHI and ODI on CT was lower than that on MAD or PAP. The residual % TST-SpO2<90% was lower than that on MAD and similar to that on PAP. The therapeutic pressure on CT was on average 9.2 cm H2O lower than that on PAP. For the 11 patients who completed CT, only CT reduced ESS compared to pretreatment value. No treatment had significant impact on % slow wave sleep or overnight change of blood pressure. For patients who completed CT, the average usage was 5.9±1.7 hr/night at 12th week and 6.4±1.5 hr/night at a median follow-up of 36.5-months.ConclusionsCombining MAD and CPAP showed additive effects on reducing AHI and ODI, and lowered the therapeutic pressures.

Support vector machine prediction of obstructive sleep apnea in a large-scale Chinese clinical sample

“…Overnight PSG (Embla N7000, Medcare Flaga, Reykjavik, Iceland) was performed as previously reported [ 20 ]. Sleep stages and respiratory events were scored according to the 2007 AASM scoring rule [ 21 ].…”

Obstrüktif uyku apne sendromu olan hastalarda CPAP tedavisinin klinik periodontal duruma etkisi: Altı yıllık takip

“…27 Sürekli pozitif hava yolu basıncı (CPAP) cihazı, OUAS için "altın standart" olarak kabul edilen tedavi aracıdır ve uyku sırasında üst hava yolunun kollabe olmasını engeller. 28,29 Nitekim OUAS tedavisinin ağız sağlığını iyileştirebileceği belirtilmiştir. 30 OUAS hastaları CPAP cihazı ile tedavi edildiğinde periodontal durumlarının nasıl etkilendiğini araştırdığımız bu çalışma, 6 yıllık CPAP tedavisi sonunda hastalarda klinik periodontal bulgularda başlangıç verilerine göre istatistiksel olarak anlamlı bir fark oluşmadığını ortaya koymaktadır.…”

Technique to Fabricate Custom Nasal Pillows and Monoblock Mandibular Advancement Device Using A Digital Workflow for Combination Therapy of Obstructive Sleep Apnea

“…These difficulties have led to innovation for alternative designs combining CPAP therapy with the oronasal mask and mandibular advancement splint (MAS). This has been shown to be a tolerable and effective therapeutic option 3,4 . It was invented by Dr. Thornton in 1993 to tackle the difficulty of treating OSA for patients with postpolio complications including paralyzed diaphragm or compromised neuromuscular drive 5 .…”